Abstract:
Abnormal morphology can be seen frequently in
the native cells of bone marrow in non-clonal
disorders like viral, bacterial, parasitic
infections, autoimmune diseases, after
chemotherapy, megaloblastic anemia, and many
more conditions. Blood counts may be normal or
decreased in these scenarios. Such morphological
atypicality can sometimes result in diagnostic
fallacy of malignancies and unnecessary
laboratory tests. When organomegaly and
lymphadenopathy are seen apart from other
clinical symptoms, it is possible for giant
proerythroblasts found in marrow aspirate of a
clinically undetected parvoviral infection to be
misidentified as high-grade lymphoma cells. We
hereby present a case of Parvoviral infection in
an immunocompetent young male who was APLA
positive. Diagnosis of Systemic Parvoviral
infection was made after Immunohistochemical
examination. Symptomatic therapy was
administered along with anticoagulants for
venous thrombosis of the lower limb veins.
During the follow-up, the patient's blood counts
were normal, and he had improved clinically. We
conclude by highlighting that all sinister
appearing cells may not be malignant.
Key
Words: Parvovirus B19, Lymphoma, Giant
Proerythroblasts, Bone Marrow, APLA
|
Introduction
Parvovirus
B19, the only known human pathogenic virus
belonging to the family of Parvoviridae is
a single stranded DNA virus.(1) Parvoviruses are
known for their wide variety of clinical
presentations, despite their propensity to damage
erythroblasts in bone marrow.(2) Coexistence of
peripheral blood cytopenia, organomegaly such as
hepatomegaly, and lymphadenopathy, in conjunction
with atypical cells in the bone marrow generally
raises the suspicion of haematolymphoid malignancy
especially Lymphoma. We present the case of a
32-year-old male, APLA positive, having clinically
undetected parvoviral infection that masqueraded
as lymphoma.
Case Report
A 32-year-old male
with primary antiphospholipid antibody syndrome
(APS) was receiving conservative treatment for
venous thrombosis of lower limb veins in a
tertiary care institution.
During the hospital
stay, he developed fever and pain abdomen with
progressive anemia and thrombocytopenia. The
hemoglobin and RBC count which were 11.3 g % and
4.26 million/cumm respectively during admission
dropped to 8.5g% and 3.4millions/cumm during the
fever episode. Platelet which was 0.89L/cmm
dropped to 0.37 L/cumm. Hepatomegaly and
retroperitoneal lymphadenopathy were detected on
an abdominal CT scan. In view of anemia and
thrombocytopenia, bone marrow aspiration and
biopsy were done.
Bone marrow was
cellular with 50 to 60% cellularity and all the
three blood cell precursors were seen in varying
stages of maturation. Along with the native marrow
cells, good number of large cells were seen having
high nucleocytoplasmic ratio (N:C), open nuclear
chromatin and prominent nucleoli (Fig1A and 1B).

|
Figure
1A- Bone Marrow Aspirate showing large,
atypical cells with high N:C ratio (black
arrow) and prominent nucleoli /? Viral
inclusions (Leishman’s stain, 100X)
Figure 1B- Bone Marrow Trephine Biopsy
showing large, atypical cell shown by
black arrow (H&E, 20X) |

|
Figure
2: Bone Marrow Aspirate showing giant
Proerythroblasts with nuclear inclusions
shown by white arrow (Leishman’s stain,
100X) |
Descriptive
diagnosis was given in bone marrow aspiration and
biopsy report and retroperitoneal lymph node
biopsy with immunohistochemical (IHC) evaluation,
and immunohistochemical examination of bone marrow
biopsy was suggested in the final report to rule
out Lymphoma.
IHC was done on bone
marrow biopsy. The large atypical looking cells
were highlighted with CD 71 (erythroid lineage
marker) and C – kit (also called CD117, expressed
predominantly in bone marrow stem/progenitor
cells) and on review of the aspiration smears, the
gigantic proerythroblasts, misinterpreted as
atypical cells, had pink intranuclear inclusions,
suggesting Parvoviral inclusion bodies (Fig 2).
The patient had been
discharged by the time of receiving IHC report and
he could not be traced. Hence serological
confirmation of the parvoviral infection was not
possible.
Paraffin block of
bone marrow biopsy was outsourced to get IHC done
and hence PCR for Parvoviral antigen was also not
possible.
Final diagnosis of
Systemic Parvoviral infection was made. Apart from
anticoagulants for venous thrombosis, patient
recovered completely with symptomatic treatment.
He was in good health six weeks following the
discharge and follow up blood counts revealed
10g/dl of hemoglobin, 3.83 million/cumm of RBCs
and 2.45 L/cumm of platelets.
Discussion
Parvovirus B19 is
generally asymptomatic in healthy adults. In a
small proportion of patients, it presents with a
broad array of systemic and haematological
manifestations. Symptomatic disease is common in
immunocompromised individuals.(3) The B19V virus
primarily affects the erythroblasts in the bone
marrow because its receptor is only present on
erythroid precursor cells.(4) Therefore, pure red
cell aplasia, the common haematological symptom,
is believed to stem from erythropoiesis being
compromised along the course of the disease.(5)
Maturation arrest
and atypia of the erythroblasts are the
characteristic bone marrow picture in parvoviral
infection. Occasionally, morphological atypia of
the normoblasts can be so extensive, which may
lead to suspicion of bone marrow infiltration with
malignancy. Clinical presentation of progressive
pancytopenia with organomegaly and lymphadenopathy
in an immunocompetent individual further bolsters
the suspicion. The present case of the young man
admitted for management of deep vein thrombosis
with prior hypercoagulable state is an example for
misinterpretation as lymphoma infiltration into
bone marrow on morphological grounds. Clinical and
ultrasonographic findings of hepatomegaly and
retroperitoneal lymphadenopathy along with
morphological atypia of the erythroblasts in the
marrow of this otherwise immunocompetent
individual were the deceptive findings.
The link between
acute parvoviral infection and lymphadenopathy was
originally observed in three of the SLE patients
who had enlargement of the epitrochlear, cervical,
and supraclavicular lymph nodes.(6) Since then,
numerous reports of parvoviral infections
presenting at different sites with lymphadenopathy
have been made.(4,7-10) Later diverse nodal
response patterns have been documented such as
necrotizing lymphadenitis, reactive hyperplasia
with varied patterns of B cell responses,(4) and
apoptotic sinus histiocytosis.(7) In many of the
case reports, the nodal enlargement has clinically
raised the suspicion of lymphoma.(7,8)
Rarely, instances of
hepatitis and hepatomegaly have been documented in
conjunction with systemic parvoviral infection;
often manifesting as jaundice, anemia, and
increased enzyme levels. Chronic hepatitis,
fulminant hepatic failure, and increased hepatic
enzyme levels are all examples of
parvovirus-induced liver illness. The
patient in this instance exhibited moderate liver
function abnormalities, including a slight rise of
bilirubin and hepatic enzymes, but after six
weeks, follow-up revealed that everything had
reverted to normal.
A varied spectrum of
clinical manifestations is the feature of viral
infections such as Parvovirus. They can manifest
in the host in unusual and unexpected clinical
circumstances. Atypia and cytopathic effects
induced by them can sometime mislead pathologists
towards a more sinister diagnosis and result in
unnecessary anxiety and laborious investigations.
References
- Heegaard ED, Brown KE. Human parvovirus B19. Clin
Microbiol Rev. 2002;15(3):485-505.
- Servey JT, Reamy BV, Hodge J. Clinical
presentations of parvovirus B19 infection. Am
Fam Physician. 2007;75(3):373-6.
- Wolfromm A, Rodriguez C, Michel M, et al.
Spectrum of adult Parvovirus B19 infection
according to the underlying predisposing
condition and proposals for clinical practice. Br
J Haematol. 2015;170(2):192-9.
- Gong L, Tian J, Feng L et al.
Parvovirus B19 infection and B-cell response
pattern in unexplained lymphadenopathy. Chin
Med J. 2023;136(18):2266-68.
- Algwaiz G, Alharbi A, Alsehaim K et al.
Hematologic Manifestations of Parvovirus B19
Infection. Hematol Oncol Stem Cell Ther.
2023;16(4):316-322.
- Meyer O, Kahn MF, Grossin M et al.
Parvovirus B19 infection can induce histiocytic
necrotizing lymphadenitis (Kikuchi's disease)
associated with systemic lupus erythematosus. Lupus.
1991 Nov;1(1):37-41.
- Knösel T, Meisel H, Borgmann A et al.
Parvovirus B19 infection associated with
unilateral cervical lymphadenopathy, apoptotic
sinus histiocytosis, and prolonged fatigue. J
Clin Pathol. 2005;58(8):872-5.
- Johnson LB, Pasumarthy A, Saravolatz LD.
Parvovirus B19 infection presenting with
necrotizing lymphadenitis. Am J Med. 2003;114(4):340-1.
- Shirono K, Tsuda H. Parvovirus B19-associated
haemophagocytic syndrome in healthy adults. Br
J Haematol. 1995;89:923– 926.
- Yufu Y, Matsumoto M, Miyamura T, et al.
Parvovirus B19-associated haemophagocytic
syndrome with lymphadenopathy resembling
histiocytic necrotizing lymphadenitis (Kikuchi’s
disease). Br J Haematol. 1997;96:868–871.
|